Quantum Biopharma Ltd (HUGE) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Quantum Biopharma Ltd   (NASDAQ: HUGE)

Quantum Biopharma Ltd Profitability Comparisons

Select each Category to receive further Information




HUGE Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q3 MRQ) - 72.42 % 66.56 % 45.67 %
Gross Margin (Q3 TTM) - 71.58 % 66.73 % 45.29 %
Gross Profit Margin 5 Yr. Avg. - 68.6 % 65.28 % 46.95 %
EBITDA Margin (Q3 MRQ) - 19.61 % 16.66 % 13.82 %
EBITDA Margin (Q3 TTM) - 16.86 % 15.07 % 17.61 %
EBITDA Margin 5 Yr. Avg. - 34.48 % 26.02 % 21.13 %
Operating Margin (Q3 MRQ) - 15.91 % 13.91 % 14.91 %
Operating Margin (Q3 TTM) - 15.31 % 13.84 % 14.87 %
Operating Margin 5 Yr. Avg. - 13.97 % 13.31 % 16 %
Pre-Tax Profit Margin (Q3 MRQ) - 12.5 % 9.21 % 10.68 %
Pre-Tax Profit Margin (Q3 TTM) - 11.78 % 8.85 % 11.08 %
Pre-Tax Profit Margin 5 Yr. Avg. - 12 % 9.87 % 11.31 %
Net Margin (Q3 MRQ) - 14.41 % 10.22 % 9.34 %
Net Margin (Q3 TTM) - 10.92 % 8 % 8.94 %
Net Margin 5 Yr. Avg. - 7.74 % 7.17 % 9.1 %